ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nausea And Vomiting Treatment Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: July 2025
|
Report Code: QYRE-Auto-32P7025
Home | Market Reports | Health| Reproductive Health
China Nausea And Vomiting Treatment Market Report Forecast 2021 2027
BUY CHAPTERS

Global Nausea And Vomiting Treatment Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-32P7025
Report
July 2025
Pages:137
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck& Co. Inc
Helsinn Group
Unimed Pharmaceuticals (AbbVie Inc.)
Kyowa Kirin
Sanofi
Qilu Pharma
Teva Pharmaceutical Industries Ltd
Taiji Group
Novartis
Heron Therapeutics
Mylan NV
Duchesnay Inc.
Pharmanovia
GSK

Nausea And Vomiting Treatment Market Size

In 2024, the global market size of Nausea And Vomiting Treatment was estimated to be worth US$ 5887 million and is forecast to reach approximately US$ 9093 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.

Nausea And Vomiting Treatment Market

Nausea And Vomiting Treatment Market

Nausea and Vomiting Treatment also called Antiemetics. Antiemetics included aprepitant, diphenhydramine, granisetron, hydroxyzine, meclizine, ondansetron, prochlorperazine, promethazine, scopolamine, metoclopramide, trimethobenzamide, palonosetron, dolasetron, and thiethylperazine, etc.
United States is the largest Nausea And Vomiting Treatment market with about 42% market share. Europe is follower, accounting for about 20% market share.Merck & Co. Inc. was the global greatest company in Nausea And Vomiting Treatment industry, with the market Share of 14% , followed by Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Atnahs Pharma UK Limited, Mylan, Duchesnay, Tesaro.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nausea And Vomiting Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nausea And Vomiting Treatment.
The Nausea And Vomiting Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nausea And Vomiting Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nausea And Vomiting Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Nausea And Vomiting Treatment Market Report

Report Metric Details
Report Name Nausea And Vomiting Treatment Market
CAGR 6.5%
Segment by Type
  • Serotonin Receptor Antagonist
  • Neurokinin NK1 Receptor Antagonist
  • Others
Segment by Application
  • CINV
  • PONV
  • Motion Sickness
  • Pregnancy
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck & Co. Inc., Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Pharmanovia, Mylan, Duchesnay, GSK
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Nausea And Vomiting Treatment in global and regional level.
  • Chapter 3: Detailed analysis of Nausea And Vomiting Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nausea And Vomiting Treatment revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Nausea And Vomiting Treatment Market share by region?

Ans: United States is the largest Nausea And Vomiting Treatment market with about 42% market share. Europe is follower, accounting for about 20% market share.

Who are the main players in the Nausea And Vomiting Treatment Market report?

Ans: The main players in the Nausea And Vomiting Treatment Market are Merck & Co. Inc., Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Pharmanovia, Mylan, Duchesnay, GSK

What are the Application segmentation covered in the Nausea And Vomiting Treatment Market report?

Ans: The Applications covered in the Nausea And Vomiting Treatment Market report are CINV, PONV, Motion Sickness, Pregnancy, Others

What are the Type segmentation covered in the Nausea And Vomiting Treatment Market report?

Ans: The Types covered in the Nausea And Vomiting Treatment Market report are Serotonin Receptor Antagonist, Neurokinin NK1 Receptor Antagonist, Others

1 Study Coverage
1.1 Nausea And Vomiting Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Nausea And Vomiting Treatment Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Serotonin Receptor Antagonist
1.2.3 Neurokinin NK1 Receptor Antagonist
1.2.4 Others
1.3 Market by Application
1.3.1 Global Nausea And Vomiting Treatment Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 CINV
1.3.3 PONV
1.3.4 Motion Sickness
1.3.5 Pregnancy
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Nausea And Vomiting Treatment Market Size Estimates and Forecasts
2.2 Nausea And Vomiting Treatment Market Size by Region: 2024 Versus 2031
2.2.1 Global Nausea And Vomiting Treatment Revenue by Region: 2020-2025
2.2.2 Global Nausea And Vomiting Treatment Revenue Forecast by Region (2026-2031)
2.2.3 Global Nausea And Vomiting Treatment Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Nausea And Vomiting Treatment Revenue by Type (2020-2031)
3.1.2 Global Nausea And Vomiting Treatment Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Nausea And Vomiting Treatment Revenue by Application (2020-2031)
3.2.2 Global Nausea And Vomiting Treatment Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Serotonin Receptor Antagonist of Nausea And Vomiting Treatment Revenue Market Share by Application
3.3.2 Neurokinin NK1 Receptor Antagonist of Nausea And Vomiting Treatment Revenue Market Share by Application
3.3.3 Others of Nausea And Vomiting Treatment Revenue Market Share by Application
4 Global Nausea And Vomiting Treatment by Company
4.1 Global Nausea And Vomiting Treatment Revenue by Company (2020-2025)
4.2 Global Nausea And Vomiting Treatment Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Nausea And Vomiting Treatment Companies around the World: Ranking by Revenue
4.3.2 Global Nausea And Vomiting Treatment Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Nausea And Vomiting Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Nausea And Vomiting Treatment Companies Headquarters & Product Type
4.4.1 Global Nausea And Vomiting Treatment Companies Headquarters
4.4.2 Date of International Companies Enter into Nausea And Vomiting Treatment Market
4.4.3 Global Nausea And Vomiting Treatment Companies Product & Service
4.4.4 Serotonin Receptor Antagonist Revenue Market Share of Nausea And Vomiting Treatment by Company
4.4.5 Neurokinin NK1 Receptor Antagonist Revenue Market Share of Nausea And Vomiting Treatment by Company
4.4.6 Others Revenue Market Share of Nausea And Vomiting Treatment by Company
4.5 Global Nausea And Vomiting Treatment Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Merck & Co. Inc.
5.1.1 Merck & Co. Inc. Corporation Information
5.1.2 Merck & Co. Inc. Description, Business Overview
5.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Products Offered
5.1.4 Merck & Co. Inc. Nausea And Vomiting Treatment Revenue and Gross Margin (2020-2025)
5.1.5 Merck & Co. Inc. Nausea And Vomiting Treatment Revenue by Product in 2024
5.1.6 Merck & Co. Inc. Nausea And Vomiting Treatment Revenue by Application in 2024
5.1.7 Merck & Co. Inc. Nausea And Vomiting Treatment Revenue by Geographic Area in 2024
5.1.8 Merck & Co. Inc. Recent Developments
5.2 Helsinn Group
5.2.1 Helsinn Group Corporation Information
5.2.2 Helsinn Group Description, Business Overview
5.2.3 Helsinn Group Nausea And Vomiting Treatment Products Offered
5.2.4 Helsinn Group Nausea And Vomiting Treatment Revenue and Gross Margin (2020-2025)
5.2.5 Helsinn Group Nausea And Vomiting Treatment Revenue by Product in 2024
5.2.6 Helsinn Group Nausea And Vomiting Treatment Revenue by Application in 2024
5.2.7 Helsinn Group Nausea And Vomiting Treatment Revenue by Geographic Area in 2024
5.2.8 Helsinn Group Recent Developments
5.3 Unimed Pharmaceuticals (AbbVie Inc.)
5.3.1 Unimed Pharmaceuticals (AbbVie Inc.) Corporation Information
5.3.2 Unimed Pharmaceuticals (AbbVie Inc.) Description, Business Overview
5.3.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Products Offered
5.3.4 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue and Gross Margin (2020-2025)
5.3.5 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue by Product in 2024
5.3.6 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue by Application in 2024
5.3.7 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue by Geographic Area in 2024
5.3.8 Unimed Pharmaceuticals (AbbVie Inc.) Recent Developments
5.4 Kyowa Kirin
5.4.1 Kyowa Kirin Corporation Information
5.4.2 Kyowa Kirin Description, Business Overview
5.4.3 Kyowa Kirin Nausea And Vomiting Treatment Products Offered
5.4.4 Kyowa Kirin Nausea And Vomiting Treatment Revenue and Gross Margin (2020-2025)
5.4.5 Kyowa Kirin Nausea And Vomiting Treatment Revenue by Product in 2024
5.4.6 Kyowa Kirin Nausea And Vomiting Treatment Revenue by Application in 2024
5.4.7 Kyowa Kirin Nausea And Vomiting Treatment Revenue by Geographic Area in 2024
5.4.8 Kyowa Kirin Recent Developments
5.5 Sanofi
5.5.1 Sanofi Corporation Information
5.5.2 Sanofi Description, Business Overview
5.5.3 Sanofi Nausea And Vomiting Treatment Products Offered
5.5.4 Sanofi Nausea And Vomiting Treatment Revenue and Gross Margin (2020-2025)
5.5.5 Sanofi Nausea And Vomiting Treatment Revenue by Product in 2024
5.5.6 Sanofi Nausea And Vomiting Treatment Revenue by Application in 2024
5.5.7 Sanofi Nausea And Vomiting Treatment Revenue by Geographic Area in 2024
5.5.8 Sanofi Recent Developments
5.6 Qilu Pharma
5.6.1 Qilu Pharma Corporation Information
5.6.2 Qilu Pharma Description, Business Overview
5.6.3 Qilu Pharma Nausea And Vomiting Treatment Products Offered
5.6.4 Qilu Pharma Nausea And Vomiting Treatment Revenue and Gross Margin (2020-2025)
5.6.5 Qilu Pharma Nausea And Vomiting Treatment Revenue by Product in 2024
5.6.6 Qilu Pharma Nausea And Vomiting Treatment Revenue by Application in 2024
5.6.7 Qilu Pharma Nausea And Vomiting Treatment Revenue by Geographic Area in 2024
5.6.8 Qilu Pharma Recent Developments
5.7 Teva Pharmaceutical Industries Ltd.
5.7.1 Teva Pharmaceutical Industries Ltd. Corporation Information
5.7.2 Teva Pharmaceutical Industries Ltd. Description, Business Overview
5.7.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Products Offered
5.7.4 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue and Gross Margin (2020-2025)
5.7.5 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue by Product in 2024
5.7.6 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue by Application in 2024
5.7.7 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue by Geographic Area in 2024
5.7.8 Teva Pharmaceutical Industries Ltd. Recent Developments
5.8 Taiji group
5.8.1 Taiji group Corporation Information
5.8.2 Taiji group Description, Business Overview
5.8.3 Taiji group Nausea And Vomiting Treatment Products Offered
5.8.4 Taiji group Nausea And Vomiting Treatment Revenue and Gross Margin (2020-2025)
5.8.5 Taiji group Nausea And Vomiting Treatment Revenue by Product in 2024
5.8.6 Taiji group Nausea And Vomiting Treatment Revenue by Application in 2024
5.8.7 Taiji group Nausea And Vomiting Treatment Revenue by Geographic Area in 2024
5.8.8 Taiji group Recent Developments
5.9 Novartis
5.9.1 Novartis Corporation Information
5.9.2 Novartis Description, Business Overview
5.9.3 Novartis Nausea And Vomiting Treatment Products Offered
5.9.4 Novartis Nausea And Vomiting Treatment Revenue and Gross Margin (2020-2025)
5.9.5 Novartis Nausea And Vomiting Treatment Revenue by Product in 2024
5.9.6 Novartis Nausea And Vomiting Treatment Revenue by Application in 2024
5.9.7 Novartis Nausea And Vomiting Treatment Revenue by Geographic Area in 2024
5.9.8 Novartis Recent Developments
5.10 Heron Therapeutics
5.10.1 Heron Therapeutics Corporation Information
5.10.2 Heron Therapeutics Description, Business Overview
5.10.3 Heron Therapeutics Nausea And Vomiting Treatment Products Offered
5.10.4 Heron Therapeutics Nausea And Vomiting Treatment Revenue and Gross Margin (2020-2025)
5.10.5 Heron Therapeutics Nausea And Vomiting Treatment Revenue by Product in 2024
5.10.6 Heron Therapeutics Nausea And Vomiting Treatment Revenue by Application in 2024
5.10.7 Heron Therapeutics Nausea And Vomiting Treatment Revenue by Geographic Area in 2024
5.10.8 Heron Therapeutics Recent Developments
5.11 Pharmanovia
5.11.1 Pharmanovia Corporation Information
5.11.2 Pharmanovia Description, Business Overview
5.11.3 Pharmanovia Nausea And Vomiting Treatment Products Offered
5.11.4 Pharmanovia Nausea And Vomiting Treatment Revenue and Gross Margin (2020-2025)
5.11.5 Pharmanovia Nausea And Vomiting Treatment Revenue by Product in 2024
5.11.6 Pharmanovia Nausea And Vomiting Treatment Revenue by Application in 2024
5.11.7 Pharmanovia Nausea And Vomiting Treatment Revenue by Geographic Area in 2024
5.11.8 Pharmanovia Recent Developments
5.12 Mylan
5.12.1 Mylan Corporation Information
5.12.2 Mylan Description, Business Overview
5.12.3 Mylan Nausea And Vomiting Treatment Products Offered
5.12.4 Mylan Nausea And Vomiting Treatment Revenue and Gross Margin (2020-2025)
5.12.5 Mylan Nausea And Vomiting Treatment Revenue by Product in 2024
5.12.6 Mylan Nausea And Vomiting Treatment Revenue by Application in 2024
5.12.7 Mylan Nausea And Vomiting Treatment Revenue by Geographic Area in 2024
5.12.8 Mylan Recent Developments
5.13 Duchesnay
5.13.1 Duchesnay Corporation Information
5.13.2 Duchesnay Description, Business Overview
5.13.3 Duchesnay Nausea And Vomiting Treatment Products Offered
5.13.4 Duchesnay Nausea And Vomiting Treatment Revenue and Gross Margin (2020-2025)
5.13.5 Duchesnay Nausea And Vomiting Treatment Revenue by Product in 2024
5.13.6 Duchesnay Nausea And Vomiting Treatment Revenue by Application in 2024
5.13.7 Duchesnay Nausea And Vomiting Treatment Revenue by Geographic Area in 2024
5.13.8 Duchesnay Recent Developments
5.14 GSK
5.14.1 GSK Corporation Information
5.14.2 GSK Description, Business Overview
5.14.3 GSK Nausea And Vomiting Treatment Products Offered
5.14.4 GSK Nausea And Vomiting Treatment Revenue and Gross Margin (2020-2025)
5.14.5 GSK Nausea And Vomiting Treatment Revenue by Product in 2024
5.14.6 GSK Nausea And Vomiting Treatment Revenue by Application in 2024
5.14.7 GSK Nausea And Vomiting Treatment Revenue by Geographic Area in 2024
5.14.8 GSK Recent Developments
6 North America
6.1 North America Nausea And Vomiting Treatment Market Size YoY Growth 2020-2031
6.2 North America Nausea And Vomiting Treatment Market Facts & Figures by Country (2020-2031)
6.3 North America Nausea And Vomiting Treatment Revenue by Type (2020-2025)
6.4 North America Nausea And Vomiting Treatment Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Nausea And Vomiting Treatment Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Nausea And Vomiting Treatment Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Nausea And Vomiting Treatment Revenue by Type (2020-2025)
7.4 Asia-Pacific Nausea And Vomiting Treatment Revenue by Application (2020-2025)
8 Europe
8.1 Europe Nausea And Vomiting Treatment Market Size YoY Growth 2020-2031
8.2 Europe Nausea And Vomiting Treatment Market Facts & Figures by Country (2020-2031)
8.3 Europe Nausea And Vomiting Treatment Revenue by Type (2020-2025)
8.4 Europe Nausea And Vomiting Treatment Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Nausea And Vomiting Treatment Market Size YoY Growth 2020-2031
9.2 Latin America Nausea And Vomiting Treatment Market Facts & Figures by Country (2020-2031)
9.3 Latin America Nausea And Vomiting Treatment Revenue by Type (2020-2025)
9.4 Latin America Nausea And Vomiting Treatment Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Nausea And Vomiting Treatment Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Nausea And Vomiting Treatment Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Nausea And Vomiting Treatment Revenue by Type (2020-2025)
10.4 Middle East and Africa Nausea And Vomiting Treatment Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Nausea And Vomiting Treatment Supply Chain Analysis
11.2 Nausea And Vomiting Treatment Key Raw Materials and Upstream Suppliers
11.3 Nausea And Vomiting Treatment Clients Analysis
11.4 Nausea And Vomiting Treatment Sales Channel and Sales Model Analysis
11.4.1 Nausea And Vomiting Treatment Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Nausea And Vomiting Treatment Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Nausea And Vomiting Treatment Distributors
12 Nausea And Vomiting Treatment Market Dynamics
12.1 Nausea And Vomiting Treatment Industry Trends
12.2 Nausea And Vomiting Treatment Market Drivers
12.3 Nausea And Vomiting Treatment Market Challenges
12.4 Nausea And Vomiting Treatment Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Merck& Co. Inc
Helsinn Group
Unimed Pharmaceuticals (AbbVie Inc.)
Kyowa Kirin
Sanofi
Qilu Pharma
Teva Pharmaceutical Industries Ltd
Taiji Group
Novartis
Heron Therapeutics
Mylan NV
Duchesnay Inc.
Pharmanovia
GSK
List of Tables
 Table 1. Global Nausea And Vomiting Treatment Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Nausea And Vomiting Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Nausea And Vomiting Treatment Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Nausea And Vomiting Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Nausea And Vomiting Treatment Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global Nausea And Vomiting Treatment Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global Nausea And Vomiting Treatment Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global Nausea And Vomiting Treatment Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global Nausea And Vomiting Treatment Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. Nausea And Vomiting Treatment Revenue by Company (2020-2025) & (US$ Million)
 Table 11. Nausea And Vomiting Treatment Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top Nausea And Vomiting Treatment Players by Revenue (US$ Million) in 2024
 Table 13. Global Nausea And Vomiting Treatment Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global Nausea And Vomiting Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nausea And Vomiting Treatment as of 2024)
 Table 15. Global Nausea And Vomiting Treatment Companies Headquarters
 Table 16. Date of International Companies Enter into Nausea And Vomiting Treatment Market
 Table 17. Global Nausea And Vomiting Treatment Companies Product & Service
 Table 18. Global Nausea And Vomiting Treatment Mergers & Acquisitions, Expansion Plans
 Table 19. Merck & Co. Inc. Corporation Information
 Table 20. Merck & Co. Inc. Description and Business Overview
 Table 21. Merck & Co. Inc. Nausea And Vomiting Treatment Product
 Table 22. Merck & Co. Inc. Nausea And Vomiting Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. Merck & Co. Inc. Revenue Proportion of Nausea And Vomiting Treatment by Product in 2024
 Table 24. Merck & Co. Inc. Revenue Proportion of Nausea And Vomiting Treatment by Application in 2024
 Table 25. Merck & Co. Inc. Revenue Proportion of Nausea And Vomiting Treatment by Geographic Area in 2024
 Table 26. Merck & Co. Inc. Recent Developments
 Table 27. Helsinn Group Corporation Information
 Table 28. Helsinn Group Description and Business Overview
 Table 29. Helsinn Group Nausea And Vomiting Treatment Product
 Table 30. Helsinn Group Nausea And Vomiting Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. Helsinn Group Revenue Proportion of Nausea And Vomiting Treatment by Product in 2024
 Table 32. Helsinn Group Revenue Proportion of Nausea And Vomiting Treatment by Application in 2024
 Table 33. Helsinn Group Revenue Proportion of Nausea And Vomiting Treatment by Geographic Area in 2024
 Table 34. Helsinn Group Recent Developments
 Table 35. Unimed Pharmaceuticals (AbbVie Inc.) Corporation Information
 Table 36. Unimed Pharmaceuticals (AbbVie Inc.) Description and Business Overview
 Table 37. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Product
 Table 38. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. Unimed Pharmaceuticals (AbbVie Inc.) Revenue Proportion of Nausea And Vomiting Treatment by Product in 2024
 Table 40. Unimed Pharmaceuticals (AbbVie Inc.) Revenue Proportion of Nausea And Vomiting Treatment by Application in 2024
 Table 41. Unimed Pharmaceuticals (AbbVie Inc.) Revenue Proportion of Nausea And Vomiting Treatment by Geographic Area in 2024
 Table 42. Unimed Pharmaceuticals (AbbVie Inc.) Recent Developments
 Table 43. Kyowa Kirin Corporation Information
 Table 44. Kyowa Kirin Description and Business Overview
 Table 45. Kyowa Kirin Nausea And Vomiting Treatment Product
 Table 46. Kyowa Kirin Nausea And Vomiting Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Kyowa Kirin Revenue Proportion of Nausea And Vomiting Treatment by Product in 2024
 Table 48. Kyowa Kirin Revenue Proportion of Nausea And Vomiting Treatment by Application in 2024
 Table 49. Kyowa Kirin Revenue Proportion of Nausea And Vomiting Treatment by Geographic Area in 2024
 Table 50. Kyowa Kirin Recent Developments
 Table 51. Sanofi Corporation Information
 Table 52. Sanofi Description and Business Overview
 Table 53. Sanofi Nausea And Vomiting Treatment Product
 Table 54. Sanofi Nausea And Vomiting Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. Sanofi Revenue Proportion of Nausea And Vomiting Treatment by Product in 2024
 Table 56. Sanofi Revenue Proportion of Nausea And Vomiting Treatment by Application in 2024
 Table 57. Sanofi Revenue Proportion of Nausea And Vomiting Treatment by Geographic Area in 2024
 Table 58. Sanofi Recent Developments
 Table 59. Qilu Pharma Corporation Information
 Table 60. Qilu Pharma Description and Business Overview
 Table 61. Qilu Pharma Nausea And Vomiting Treatment Product
 Table 62. Qilu Pharma Nausea And Vomiting Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. Qilu Pharma Revenue Proportion of Nausea And Vomiting Treatment by Product in 2024
 Table 64. Qilu Pharma Revenue Proportion of Nausea And Vomiting Treatment by Application in 2024
 Table 65. Qilu Pharma Revenue Proportion of Nausea And Vomiting Treatment by Geographic Area in 2024
 Table 66. Qilu Pharma Recent Developments
 Table 67. Teva Pharmaceutical Industries Ltd. Corporation Information
 Table 68. Teva Pharmaceutical Industries Ltd. Description and Business Overview
 Table 69. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Product
 Table 70. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 71. Teva Pharmaceutical Industries Ltd. Revenue Proportion of Nausea And Vomiting Treatment by Product in 2024
 Table 72. Teva Pharmaceutical Industries Ltd. Revenue Proportion of Nausea And Vomiting Treatment by Application in 2024
 Table 73. Teva Pharmaceutical Industries Ltd. Revenue Proportion of Nausea And Vomiting Treatment by Geographic Area in 2024
 Table 74. Teva Pharmaceutical Industries Ltd. Recent Developments
 Table 75. Taiji group Corporation Information
 Table 76. Taiji group Description and Business Overview
 Table 77. Taiji group Nausea And Vomiting Treatment Product
 Table 78. Taiji group Nausea And Vomiting Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 79. Taiji group Revenue Proportion of Nausea And Vomiting Treatment by Product in 2024
 Table 80. Taiji group Revenue Proportion of Nausea And Vomiting Treatment by Application in 2024
 Table 81. Taiji group Revenue Proportion of Nausea And Vomiting Treatment by Geographic Area in 2024
 Table 82. Taiji group Recent Developments
 Table 83. Novartis Corporation Information
 Table 84. Novartis Description and Business Overview
 Table 85. Novartis Nausea And Vomiting Treatment Product
 Table 86. Novartis Nausea And Vomiting Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 87. Novartis Revenue Proportion of Nausea And Vomiting Treatment by Product in 2024
 Table 88. Novartis Revenue Proportion of Nausea And Vomiting Treatment by Application in 2024
 Table 89. Novartis Revenue Proportion of Nausea And Vomiting Treatment by Geographic Area in 2024
 Table 90. Novartis Recent Developments
 Table 91. Heron Therapeutics Corporation Information
 Table 92. Heron Therapeutics Description and Business Overview
 Table 93. Heron Therapeutics Nausea And Vomiting Treatment Product
 Table 94. Heron Therapeutics Nausea And Vomiting Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 95. Heron Therapeutics Revenue Proportion of Nausea And Vomiting Treatment by Product in 2024
 Table 96. Heron Therapeutics Revenue Proportion of Nausea And Vomiting Treatment by Application in 2024
 Table 97. Heron Therapeutics Revenue Proportion of Nausea And Vomiting Treatment by Geographic Area in 2024
 Table 98. Heron Therapeutics Recent Developments
 Table 99. Pharmanovia Corporation Information
 Table 100. Pharmanovia Description and Business Overview
 Table 101. Pharmanovia Nausea And Vomiting Treatment Product
 Table 102. Pharmanovia Nausea And Vomiting Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Pharmanovia Revenue Proportion of Nausea And Vomiting Treatment by Product in 2024
 Table 104. Pharmanovia Revenue Proportion of Nausea And Vomiting Treatment by Application in 2024
 Table 105. Pharmanovia Revenue Proportion of Nausea And Vomiting Treatment by Geographic Area in 2024
 Table 106. Pharmanovia Recent Developments
 Table 107. Mylan Corporation Information
 Table 108. Mylan Description and Business Overview
 Table 109. Mylan Nausea And Vomiting Treatment Product
 Table 110. Mylan Nausea And Vomiting Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 111. Mylan Revenue Proportion of Nausea And Vomiting Treatment by Product in 2024
 Table 112. Mylan Revenue Proportion of Nausea And Vomiting Treatment by Application in 2024
 Table 113. Mylan Revenue Proportion of Nausea And Vomiting Treatment by Geographic Area in 2024
 Table 114. Mylan Recent Developments
 Table 115. Duchesnay Corporation Information
 Table 116. Duchesnay Description and Business Overview
 Table 117. Duchesnay Nausea And Vomiting Treatment Product
 Table 118. Duchesnay Nausea And Vomiting Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 119. Duchesnay Revenue Proportion of Nausea And Vomiting Treatment by Product in 2024
 Table 120. Duchesnay Revenue Proportion of Nausea And Vomiting Treatment by Application in 2024
 Table 121. Duchesnay Revenue Proportion of Nausea And Vomiting Treatment by Geographic Area in 2024
 Table 122. Duchesnay Recent Developments
 Table 123. GSK Corporation Information
 Table 124. GSK Description and Business Overview
 Table 125. GSK Nausea And Vomiting Treatment Product
 Table 126. GSK Nausea And Vomiting Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 127. GSK Revenue Proportion of Nausea And Vomiting Treatment by Product in 2024
 Table 128. GSK Revenue Proportion of Nausea And Vomiting Treatment by Application in 2024
 Table 129. GSK Revenue Proportion of Nausea And Vomiting Treatment by Geographic Area in 2024
 Table 130. GSK Recent Developments
 Table 131. North America Nausea And Vomiting Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 132. North America Nausea And Vomiting Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 133. North America Nausea And Vomiting Treatment Revenue by Type (2020-2025) & (US$ Million)
 Table 134. North America Nausea And Vomiting Treatment Revenue by Application (2020-2025) & (US$ Million)
 Table 135. Asia-Pacific Nausea And Vomiting Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 136. Asia-Pacific Nausea And Vomiting Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 137. Asia-Pacific Nausea And Vomiting Treatment Revenue by Type (2020-2025) & (US$ Million)
 Table 138. Asia-Pacific Nausea And Vomiting Treatment Revenue by Application (2020-2025) & (US$ Million)
 Table 139. Europe Nausea And Vomiting Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 140. Europe Nausea And Vomiting Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 141. Europe Nausea And Vomiting Treatment Revenue by Type (2020-2025) & (US$ Million)
 Table 142. Europe Nausea And Vomiting Treatment Revenue by Application (2020-2025) & (US$ Million)
 Table 143. Latin America Nausea And Vomiting Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 144. Latin America Nausea And Vomiting Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 145. Latin America Nausea And Vomiting Treatment Revenue by Type (2020-2025) & (US$ Million)
 Table 146. Latin America Nausea And Vomiting Treatment Revenue by Application (2020-2025) & (US$ Million)
 Table 147. Middle East and Africa Nausea And Vomiting Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 148. Middle East and Africa Nausea And Vomiting Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 149. Middle East and Africa Nausea And Vomiting Treatment Revenue by Type (2020-2025) & (US$ Million)
 Table 150. Middle East and Africa Nausea And Vomiting Treatment Revenue by Application (2020-2025) & (US$ Million)
 Table 151. Nausea And Vomiting Treatment Key Raw Materials, Industry Status and Trend
 Table 152. Nausea And Vomiting Treatment Key Raw Materials and Upstream Suppliers
 Table 153. Nausea And Vomiting Treatment Clients Status and Trend
 Table 154. Nausea And Vomiting Treatment Typical Clients
 Table 155. Nausea And Vomiting Treatment Distributors
 Table 156. Nausea And Vomiting Treatment Market Trends
 Table 157. Nausea And Vomiting Treatment Market Drivers
 Table 158. Nausea And Vomiting Treatment Market Challenges
 Table 159. Nausea And Vomiting Treatment Market Restraints
 Table 160. Research Programs/Design for This Report
 Table 161. Key Data Information from Secondary Sources
 Table 162. Key Data Information from Primary Sources


List of Figures
 Figure 1. Nausea And Vomiting Treatment Product Picture
 Figure 2. Global Nausea And Vomiting Treatment Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Nausea And Vomiting Treatment Revenue Market Share by Type in 2024 & 2031
 Figure 4. Serotonin Receptor Antagonist Product Picture
 Figure 5. Neurokinin NK1 Receptor Antagonist Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Nausea And Vomiting Treatment Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 8. Global Nausea And Vomiting Treatment Revenue Market Share by Application in 2024 & 2031
 Figure 9. CINV
 Figure 10. PONV
 Figure 11. Motion Sickness
 Figure 12. Pregnancy
 Figure 13. Others
 Figure 14. Nausea And Vomiting Treatment Report Years Considered
 Figure 15. Global Nausea And Vomiting Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Nausea And Vomiting Treatment Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Nausea And Vomiting Treatment Market Size Market Share by Region: 2024 Versus 2031
 Figure 18. Global Nausea And Vomiting Treatment Revenue Market Share by Region (2020-2031)
 Figure 19. Global Nausea And Vomiting Treatment Revenue Market Share Forecast by Type (2020-2031)
 Figure 20. Global Nausea And Vomiting Treatment Revenue Market Share Forecast by Application (2020-2031)
 Figure 21. Serotonin Receptor Antagonist of Nausea And Vomiting Treatment Revenue Market Share by Application, 2024 VS 2031
 Figure 22. Neurokinin NK1 Receptor Antagonist of Nausea And Vomiting Treatment Revenue Market Share by Application, 2024 VS 2031
 Figure 23. Others of Nausea And Vomiting Treatment Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Nausea And Vomiting Treatment Revenue Share by Company (2024)
 Figure 25. Nausea And Vomiting Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Serotonin Receptor Antagonist Revenue Proportion by Company in 2024
 Figure 27. Neurokinin NK1 Receptor Antagonist Revenue Proportion by Company in 2024
 Figure 28. Others Revenue Proportion by Company in 2024
 Figure 29. North America Nausea And Vomiting Treatment Revenue 2020-2031 (US$ Million)
 Figure 30. North America Nausea And Vomiting Treatment Revenue Market Share by Type (2020-2025)
 Figure 31. North America Nausea And Vomiting Treatment Revenue Market Share by Application (2020-2025)
 Figure 32. Asia-Pacific Nausea And Vomiting Treatment Revenue 2020-2031 (US$ Million)
 Figure 33. Asia-Pacific Nausea And Vomiting Treatment Revenue Market Share by Region (2020-2031)
 Figure 34. Asia-Pacific Nausea And Vomiting Treatment Revenue Market Share by Type (2020-2025)
 Figure 35. Asia-Pacific Nausea And Vomiting Treatment Revenue Market Share by Application (2020-2025)
 Figure 36. Europe Nausea And Vomiting Treatment Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 37. Europe Nausea And Vomiting Treatment Revenue Market Share by Country (2020-2031)
 Figure 38. Europe Nausea And Vomiting Treatment Revenue Market Share by Type (2020-2025)
 Figure 39. Europe Nausea And Vomiting Treatment Revenue Market Share by Application (2020-2025)
 Figure 40. Latin America Nausea And Vomiting Treatment Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 41. Latin America Nausea And Vomiting Treatment Revenue Market Share by Country (2020-2031)
 Figure 42. Latin America Nausea And Vomiting Treatment Revenue Market Share by Type (2020-2025)
 Figure 43. Latin America Nausea And Vomiting Treatment Revenue Market Share by Application (2020-2025)
 Figure 44. Middle East and Africa Nausea And Vomiting Treatment Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 45. Middle East and Africa Nausea And Vomiting Treatment Revenue Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Nausea And Vomiting Treatment Revenue Market Share by Type (2020-2025)
 Figure 47. Middle East and Africa Nausea And Vomiting Treatment Revenue Market Share by Application (2020-2025)
 Figure 48. Nausea And Vomiting Treatment Supply Chain (Upstream and Downstream Market)
 Figure 49. Global Production Market Share of Nausea And Vomiting Treatment Raw Materials by Region in 2024
 Figure 50. Nausea And Vomiting Treatment Distribution Channels
 Figure 51. Global Nausea And Vomiting Treatment Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 52. Global Nausea And Vomiting Treatment Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 53. Bottom-up and Top-down Approaches for This Report
 Figure 54. Data Triangulation
 Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Anti Emetic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Nausea and Vomiting Device Market Research Report 2024
Antiemetics for Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Nausea and Vomiting Healthcare Device Market Research Report 2024
Global Anti Nausea and Vomiting Band Market Research Report 2025
Global Gastroparesis Treatment Products Market Insights Forecast to 2030
Global Aprepitant Market Insights Forecast to 2030
Global Electronic Antiemetic Device Market Research Report 2024
Global Medical Electronic Antiemetic Device Market Research Report 2024
Global Household Electronic Antiemetic Device Market Research Report 2024
Chemotheraphy induced Nausea and Vomitting Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antiemetic Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Watch Antiemetic Device Market Research Report 2024
OTC Anti nausea Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical Wrist Anti vomiting Device Market Research Report 2024
Global Granisetron HCl API Market Research Report 2024
Global Household Watch Antiemetic Device Market Research Report 2024
Granisetron Base Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Digestive Drugs Market Insights Forecast to 2030
Global Wearable Drug Induced Antiemetic Device Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions